首页> 外文OA文献 >Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients

【2h】

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients

机译：TiM-3，LAG-3，PD-1和PD-L1中的丰富表达作为间皮瘤患者的灭活中的免疫疗法检查点靶标

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Elly Marcq; Jorrit De Waele; Jonas Van Audenaerde; Eva Lion; Eva Santermans; Niel Hens; Patrick Pauwels; Jan P. van Meerbeeck; Evelien L.J. Smits;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors [J] . Jaeyun Jane Wang, Peter Burger, Janis Taube, Cureus. . 2019,第12期

机译：Melanoma中的PD-L1，PD-1，LAG-3和TIM-3：与相应的颅外肿瘤相比脑转移中的表达
2. An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression [J] . Adrian E Rice, Yvette Latchman, Joseph P Balint, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：HPV-E6 / E7免疫疗法加PD-1检查点抑制可导致肿瘤消退并减少PD-L1表达
3. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1 [J] . Patera Andriani C., Drewry Anne M., Chang Katherine, Journal of Leukocyte Biology: An Official Publication of the Reticuloendothelial Society . 2016,第6期

机译：一线科学：败血症患者的免疫功能缺陷与PD-1或PD-L1表达有关，可以通过靶向PD-1或PD-L1的抗体来修复
4. The Study on the Relationship between PD-1/PD-L1 mRNA Expression and Progression in HIV/AIDS Patients [C] . Wu Yan-ling, Ding Yan-ping, Cheng Lei, Biomedical Engineering and Biotechnology (iCBEB), 2012 International Conference on . 2012

机译：HIV / AIDS患者PD-1 / PD-L1 mRNA表达与疾病进展关系的研究
5. Expression and Function of Co-inhibitory Receptors PD-1, TIGIT, TIM-3, and LAG-3 in Systemic Sclerosis [D] . Fleury, Michelle. 2018

机译：共抑制性受体PD-1，TIGIT，TIM-3和LAG-3在系统性硬化中的表达和功能
6. Abundant expression of TIM-3 LAG-3 PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients [O] . Elly Marcq, Jorrit De Waele, Jonas Van Audenaerde, 2017

机译：间皮瘤患者积液中TIM-3LAG-3PD-1和PD-L1作为免疫治疗检查点靶标的大量表达
7. Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells [O] . 2019

机译：乳腺癌细胞和PD-1 / PD-L1阻断上调了CD4 + T细胞中PD-1，CTLA-4，TIM-3和LAG-3免疫检查点的表达

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients

著录项

引文网络

相似文献

相关主题

期刊订阅